Cargando…
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
A 51-year-old woman had been receiving medical treatment for asthma since she was 21 years old. However, her asthma was poorly controlled despite treatment involving combination inhalation of high-dose corticosteroid and long-acting β (2)-aderenergic agonist (LABA) and regularly taking oral steroids...
Autores principales: | Okude, Azusa, Tagaya, Etsuko, Kondo, Mitsuko, Nonaka, Manabu, Tamaoki, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512216/ https://www.ncbi.nlm.nih.gov/pubmed/23227405 http://dx.doi.org/10.1155/2012/340525 |
Ejemplares similares
-
Optimal control of asthma improved eosinophilic otitis media
por: Seo, Yukako, et al.
Publicado: (2018) -
Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment
por: Tanaka, Yukako, et al.
Publicado: (2013) -
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007) -
Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022) -
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
por: D’Amato, Gennaro, et al.
Publicado: (2014)